Garrett Knappe

Ultromics - EchoGo Heart Failure and EchoGo Amyloidosis

[Garrett Knappe @TimeForAKnappe]

@Mike_kim714 @Titleist 67

[Ultromics @ultromics]

Big news! 🥳 We have secured investment from the @American_Heart Go Red for Women® Venture Fund, accelerating our work to improve earlier detection of #HFpEF — a condition that disproportionately affects women and is often missed: https://t.co/i0k22tOXzC #CardioTwitter

[Ultromics @ultromics]

It’s #WorldHeartDay ❤️ Ultromics is redefining cardiovascular care, using AI to help identify patients at risk of complex cardiac diseases, supporting early detection & treatment. Dr. Pellikka, Dr. Slivnick, & Dr. Jamal share their experiences.

▶️ Watch: https://t.co/H0v67e5m4X

[Ultromics @ultromics]

EchoGo® Amyloidosis could improve early detection of cardiac amyloidosis. New study presented at #ASE2025 shows EchoGo® improved detection & reduced unnecessary testing. https://t.co/wpDjiR2G5N #CardioTwitter

[Ultromics @ultromics]

Ultromics has been recognized as part of @TechNation's #FutureFifty! It’s an incredible milestone, highlighting our impact in shaping the future of healthcare innovation. Proud to stand alongside an amazing roster of the best in UK innovation! https://t.co/DxRCe31QoX

[Ultromics @ultromics]

📢 #ASE2025 speaker spotlight! Dr. Slivnick from @UChicago — lead author of the landmark EHJ study on EchoGo® Amyloidosis — will be sharing results from the paper this Sunday! See how our FDA-cleared tools are supporting earlier recognition of cardiac amyloidosis #EchoFirst @ASE360

[Ultromics @ultromics]

We’re excited to welcome Garrett Knappe as Regional Sales Director for the U.S. Midwest! With over 12 years of experience in MedTech, Garrett brings a strong background in strategic commercial leadership and a commitment to delivering exceptional customer experiences—all in support of our mission to transform the diagnosis of heart disease through AI #EchoGo

[Dr.Patricia Pellikka @pattypellikka]

Interested in AI echo? Please check out this current review

[Ultromics @ultromics]

Thank you @Nasdaq for celebrating Ultromics’ $55M Series C milestone on the Nasdaq Tower in Times Square! 🥳

Grateful for your support as we accelerate our mission to advance earlier detection and treatment of heart failure with AI #DigitalHealth #Cardiology #CardioTwitter

[Ross Upton PhD @DrRossUpton]

🚨From 0 to C - I’m proud to share @ultromics has raised a $55M Series C!🚨

https://t.co/F3OCRAseyZ

[Ultromics @ultromics]

Today marks a historic milestone for Ultromics: we’ve raised $55M in Series C funding! https://t.co/Kas6hJHiOv Co-led by Lightrock, L&G, and Allegis Capital, with support from Oxford Science Enterprises, GV, Blue Venture Fund, Oxford University, UChicago Medicine Ventures, and UPMC Enterprises.

We are proud to continue our mission to transform heart disease detection and help drive earlier diagnosis through AI.

[Ultromics @ultromics]

Our #EHJ study is making headlines! We’re proud to see @Medscape feature our research on using AI to detect cardiac amyloidosis. EchoGo® Amyloidosis is FDA-cleared and can identify cardiac amyloidosis from a single routine echo view: https://t.co/8g2UO0zluH #Cardiology #EchoGo

[Ultromics @ultromics]

New multi-center validation in #JACCAdvances compared multiple algorithms for detecting Cardiac #Amyloidosis. EchoGo® Amyloidosis demonstrated the highest sensitivity and accuracy (AUC 0.92).
See paper: https://t.co/98YFKZhUvr

The study highlights the growing role of AI in enabling earlier and supporting detection, and shows AI outperforming traditional EHR and rules-based methods #CardioEd #CardioTwitter #EchoFirst

[Ultromics @ultromics]

📢 New #EHJ study! Our AI screening tool for echo — EchoGo® Amyloidosis — detects cardiac amyloidosis, a life-threatening condition, with high accuracy. Developed with @MayoClinic @UChicago, tested with 18 global sites. See paper & release: https://t.co/8P3D0QzHjI #CardioTwitter

[Garrett Knappe @TimeForAKnappe]

@SangjinLee17 @SangjinLee17 Great to hear about implementing AI to boost physician efficiency! You might also find value in Ultromics EchoGo Heart Failure—it’s designed to support clinicians in identifying and managing HFpEF and Amyloidosis patients more effectively!

[Garrett Knappe @TimeForAKnappe]

Can we get a live look at @ColtKnost when JT canned that eagle on 18 to go from 13th to T4!?! #cash #easssyyyyymoney

[Garrett Knappe @TimeForAKnappe]

@trevesius @Matt_Pinner Such a classic! Thank you for sharing 😘😘

[Haemonetics Corp @HaemoneticsCorp]

Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire: https://t.co/xpFgOmHYBw

[Garrett Knappe @TimeForAKnappe]

@ColtKnost @thesleezyman appreciate the shoutout on the pod boys. We will get those shirts made for next year. Colt, 6XL?

[Garrett Knappe @TimeForAKnappe]

@ColtKnost @SRTheegala 🤣🤣🤣 had to get creative on how to get your attention! Great meeting you, too. Thank you again for taking the time. Will be listening to the pod this week for a quick shoutout 🤷🏻‍♂️

[Garrett Knappe @TimeForAKnappe]

The golf community is amazing. Had the opportunity to meet @ColtKnost who promised to take the time to introduce himself, then @SRTheegala dad took the time to say hi for a picture. Thank you both.